Opko unit GeneDx CEO Stueland named 2026 Fierce 50 honoree for health equity - OPK News | RalliesOpko unit GeneDx CEO Stueland named 2026 Fierce 50 honoree for health equity
O
OPK• GeneDx CEO honored for health equity work
- Opko Health subsidiary GeneDx CEO Katherine Stueland was named a 2026 Fierce 50 honoree for Health Equity.
- The award highlights GeneDx’s push to make earlier rare-disease diagnosis a standard part of clinical care.
- GeneDx cited its Infinity genomic dataset as a core asset supporting broader use of genomic medicine at scale.
RLMD
•
